Artificial intelligence (AI) has undergone rapid development in recent years and has been successfully applied to real-world problems such as drug design. In this chapter, we review recent applications of AI to problems in drug design including virtual screening, computer-aided synthesis planning, and de novo molecule generation, with a focus on the limitations of the application of AI therein and opportunities for improvement. Furthermore, we discuss the broader challenges imposed by AI in translating theoretical practice to real-world drug design; including quantifying prediction uncertainty and explaining model behavior.
Keywords: AI; Artificial intelligence; CASP; Computer-aided synthesis planning; De novo molecule generation; Drug design; Generative models; ML; Machine learning; Model interpretability; Prediction uncertainty; Virtual screening.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.